No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects
-
Breast Neoplasms / blood supply
-
Breast Neoplasms / mortality
-
Breast Neoplasms / therapy*
-
Combined Modality Therapy
-
Complementary Therapies*
-
Designer Drugs / administration & dosage
-
Designer Drugs / adverse effects
-
Female
-
Genetic Therapy
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Neoplasm Metastasis
-
Neovascularization, Pathologic / prevention & control
-
Survival Rate
Substances
-
Antineoplastic Agents
-
Designer Drugs